Launch week offerEnds in00h00m00s

annual Promonthly Pro

Pranita D Tamma

Professor

Children's Hospital of Philadelphia

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States Professors in Microbiology Microbiology professors in United States

Articles (21)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Collaborators (11)

Navaneeth Narayanan

Clinical Assistant Professor

Rutgers New Jersey Medical School

UNITED STATES

View details

Dariusz Hareza

Assistant Professor of Medicine (Infectious Diseases)

Northwestern Medicine

UNITED STATES

View details

Kimberly C Claeys

University of Maryland School of Pharmacy

UNITED STATES

View details

Emily McDonald

Associate professor of medicine

McGill University Health Centre

CANADA

View details

Egon A Ozer

Northwestern University Feinberg School of Medicine

UNITED STATES

View details

Alan R. Hauser

Northwestern University

UNITED STATES

View details

Zackery Bulman

University of Chicago

UNITED STATES

View details

Ashlan J Kunz Coyne

Assistant Professor

University of Kentucky College of Pharmacy

UNITED STATES

View details

Aaron Milstone

Professor

Johns Hopkins University

UNITED STATES

View details

Thomas P. Lodise

UNITED STATES

View details

Erin K McCreary

University of Pittsburgh School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pranita D Tamma

Research Interests

Make your next move.

Explore related searches

Articles (21)

Comparative outcomes of ceftazidime-avibactam versus meropenem-vaborbactam for KPC-producing Enterobacterales infections

Aminoglycosides enhance meropenem/vaborbactam activity against KPC-producing Klebsiella pneumoniae in the hollow fiber infection model.

Infectious Diseases Society of America 2026 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections

Comparative evaluation of the activity of novel β-lactam antibiotics against difficult-to-treat Pseudomonas aeruginosa clinical isolates

Comparative in vitro activity of aztreonam–avibactam and aztreonam plus ceftazidime–avibactam against Stenotrophomonas maltophilia complex

Activity of novel antibiotics against dual metallo-Beta-lactamase producing Enterobacter hormaechei clinical isolates

Establishing the Optimal Ceftriaxone MIC for Predicting ESBL Production in Bloodstream Infections

Are bactericidal antibiotics necessary to effectively treat bloodstream infections?

Molecular epidemiology of β-lactamases in ceftriaxone-resistant Enterobacterales bloodstream infections in the mid-Atlantic United States.

How accurate is ceftriaxone at predicting susceptibility of enterobacterales isolates to oral higher-generation cephalosporins?

Revisiting REVISIT: The Case for Ceftazidime/Avibactam Plus Aztreonam

Do Aminopenicillins Have a Role in Treating Ampicillin-Resistant Enterococcus UTIs?

Investigating the Molecular Epidemiology of Extended-Spectrum β-Lactamase-Producing Enterobacterales (ESBL-E) Among Patients Admitted to the Intensive Care Unit

Case Commentary: Overcoming intrinsic resistance—the successful use of aztreonam and avibactam for Stenotrophomonas maltophilia meningitis

Cefepime-zidebactam therapy for extensively drug-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae infection as a bridge to liver transplantation

Microbiome and resistome characterization of patients colonized with carbapenem-resistant Enterobacterales by long-read metagenomic next-generation sequencing of rectal swabs

The Effectiveness of Newer Beta-Lactams for the Treatment of Antimicrobial-Resistant Gram-Negative Meningitis

Inferring Amoxicillin-Clavulanate Susceptibility From Ampicillin-Sulbactam Susceptibility Against Common Enterobacterales Species

Fighting resistance with redundancy: a path forward for treating antimicrobial-resistant infections?

Cefiderocol “under siege”? Understanding the rise of NDM-mediated resistance to novel agents

Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study

Collaborators (11)

Navaneeth Narayanan

Dariusz Hareza

Kimberly C Claeys

Emily McDonald

Egon A Ozer

Alan R. Hauser

Zackery Bulman

Ashlan J Kunz Coyne

Aaron Milstone

Thomas P. Lodise

Erin K McCreary

Make your next move.